These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2905866)

  • 1. Histamine H2-receptor blocking activity of ranitidine and lamtidine analogues containing aminomethyl-substituted aliphatic systems.
    Orsetti M
    Agents Actions; 1988 Dec; 25(3-4):291-5. PubMed ID: 2905866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of new histamine H2-receptor antagonists related to cimetidine, ranitidine and lamtidine.
    Orsetti M; Sorba G
    J Pharm Pharmacol; 1988 Jan; 40(1):31-4. PubMed ID: 2896770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New ranitidine analogues containing the 2-aminobenzimidazole moiety: in vivo and in vitro histamine H2-receptor blocking activity.
    Orsetti M; Oggero L
    Agents Actions; 1988 Jun; 24(1-2):109-13. PubMed ID: 2900598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an accessory binding area in the histamine H2 receptor.
    Orsetti M; Sorba G
    Eur J Pharmacol; 1991 Jul; 207(3):259-65. PubMed ID: 1680063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of the new histamine H2-receptor antagonist zolantidine at cardiac and gastric H2-receptors.
    Coruzzi G; Adami M; Pozzoli C; Poli E; Bertaccini G
    Pharmacology; 1994 Feb; 48(2):69-76. PubMed ID: 7907797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
    Palacios B; Montero MJ; Sevilla MA; Román LS
    Br J Pharmacol; 1995 May; 115(1):57-66. PubMed ID: 7647984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.
    Daly MJ; Humphray JM; Stables R
    Br J Pharmacol; 1981 Jan; 72(1):49-54. PubMed ID: 6112034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist.
    Palacios B; Montero MJ; Sevilla MA; San Román L
    Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacology of two new histamine receptor antagonists related to ranitidine.
    Navarro JJ; Almeida JF; Anaya J; Moran JR; Grande M; Caballero MC; Palacios B; Montero MJ; San Roman L
    Pharmazie; 1995 Jan; 50(1):12-5. PubMed ID: 7886119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H2-antagonists--past, present and future.
    Brittain RT; Jack D
    J Clin Gastroenterol; 1983; 5 Suppl 1():71-9. PubMed ID: 6140285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential histamine H2-receptor antagonists. Synthesis, structure and activity of a few open models related to classical H2-antagonists.
    Sorba G; Fruttero R; Gasco A; Orsetti M
    Arzneimittelforschung; 1989 Sep; 39(9):1092-6. PubMed ID: 2574039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity characterization of an H2-receptor antagonist, 3-amino-4-[4-[4-(1-piperidinomethyl)-2-pyridyloxy]-cis-2-++ +butenylamino]- 3-cyclobutene-1,2-dione hydrochloride (T-066), involved in the insurmountable antagonism against histamine-induced positive chronotropic action in guinea pig atria.
    Kijima H; Isobe Y; Muramatsu M; Yokomori S; Suzuki M; Higuchi S
    Biochem Pharmacol; 1998 Jan; 55(2):151-7. PubMed ID: 9448737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine H2-receptor blocking activity of ranitidine analogues containing 3-amino-4-alkylaminofurazan moieties.
    Orsetti M; Oggero L; Sorba G
    Pharmacol Res; 1989; 21(1):115-6. PubMed ID: 2566988
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism.
    Ichikawa T; Ishihara K; Saigenji K; Hotta K
    Br J Pharmacol; 1997 Nov; 122(6):1230-6. PubMed ID: 9401791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac and gastric effects of histamine H2 receptor antagonists: no evidence for a correlation between lipophilicity and receptor affinity.
    Coruzzi G; Adami M; Pozzoli C; Giorgi F; Bertaccini G
    Br J Pharmacol; 1996 Aug; 118(7):1813-21. PubMed ID: 8842448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
    Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
    Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P
    Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine and other H2-receptor antagonists: recent developments.
    Daly MJ; Price BJ
    Prog Med Chem; 1983; 20():337-68. PubMed ID: 6138817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.